Medical Devices: Page 153


  • Image attribution tooltip
    Express Scripts Holding Co.
    Image attribution tooltip

    Express Scripts to launch formulary for apps, medical devices

    The pharmacy benefit manager says its new formulary will include digital health solutions for a host of chronic and complex conditions, including diabetes, cardiovascular, pulmonary and behavioral health issues.

    By Rebecca Pifer • May 17, 2019
  • Smiths Medical lobbies White House for better device-based opioid alternative reimbursement

    The medical device industry is taking an all hands on deck approach to convince CMS for better payment in the Hospital Outpatient Prospective Payment System proposed rule.

    By David Lim • May 17, 2019
  • Front sign of FDA building Explore the Trendline
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Medical device safety in spotlight after high profile recalls

    From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.

    By MedTech Dive staff
  • Canada raises medical device regulatory fees

    The final fee schedule reflects a compromise after industry pushed back against higher rates initially proposed.

    By May 17, 2019
  • Newly independent Alcon leans on surgical unit while awaiting key product launches

    The full year outlook reflects rising sales of Alcon's PanOptix intraocular lenses, offset by loss of vision care market share.

    By May 17, 2019
  • FDA classes J&J stapler recall as high risk ahead of advisory panel

    More than 92,000 of the devices made by the pharma's Ethicon unit are implicated in the U.S. recall.

    By May 17, 2019
  • FDA calls Essure postmarket study progress 'adequate' in adverse event update

    The agency said it received roughly 6,000 medical device reports related to the permanent birth control implant last year. Bayer halted U.S. sales at the end of 2018, but doctors can implant the device through the end of 2019.

    By Maria Rachal • May 16, 2019
  • Image attribution tooltip
    Cole Rosengren
    Image attribution tooltip

    Massachusetts grows medtech exports, but decline in clearances spurs R&D rethink

    The 7.7% uptick in 2018 exports was countered by a 17% decline in 510(k) clearances.

    By May 16, 2019
  • Titan Medical's losses balloon as robotic surgery R&D drive accelerates

    The company plans to file for a CE mark and 510(k) clearance for its robotic surgery platform by the end of the fiscal year. It aims to start early U.S. commercialization in 2020.

    By May 16, 2019
  • Abbott, NIH collaborate on neuroscience research

    The company will contribute its neuromodulation technologies to the National Institutes of Health's work on brain disorders.

    By May 15, 2019
  • Haemonetics sells plant, gains expanded indication for blood analyzer systems

    After reporting a 6.7% jump in quarterly revenue, the blood technologies maker has offloaded a manufacturing site to CSL Plasma and received clearance for use of its hemostasis analyzer system in adult trauma settings.

    By May 15, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Medical equipment hit by escalation of US-China trade war

    Between tariffs already enacted and an additional $300 billion in products on the table, imaging equipment, diagnostic reagents, surgical gloves and contact lenses stand to be among the medical devices affected.

    By May 15, 2019
  • CMS will weigh broader mitral valve repair NCD, analysts predict

    Cowen analysts think Medicare's Coverage Analysis Group is likely to reconsider the national coverage determination for mitral valve repair in the second half of the year, which could benefit MitraClip maker Abbott.

    By May 14, 2019
  • Same-day upper and lower endoscopies improve care, costs: JAMA

    Johns Hopkins researchers used Medicare claims data to identify patterns suggesting overuse of different-day scheduling, especially when physician offices and freestanding ambulatory surgery centers did the scheduling.

    By May 14, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA extends Abiomed heart pump use to 14 days

    The new label more than doubles authorized length of use of the pumps and positions physicians to give critically ill patients longer to recover before deciding on next steps.

    By May 14, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AliveCor snags FDA clearance for six-lead EKG

    Alongside an April clearance for its KardiaAI software to help identify bradycardia and tachycardia, the company is positioning itself to compete with the latest Apple Watch's electrocardiogram function.

    By David Lim • May 13, 2019
  • Medtronic, Boston Scientific unveil ICD data

    Medtronic also released analyses indicating implantable cardioverter defibrillators and cardiac resynchronization therapy devices are underutilized in patients medically indicated for the treatments.

    By May 13, 2019
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    LabCorp to sell Qiagen companion diagnostic for bladder cancer

    The test is designed to assess whether patients with urothelial cancer are eligible for treatment with Johnson & Johnson’s newly approved therascreen fibroblast growth factor receptor kinase inhibitor Balversa.

    By May 13, 2019
  • Medicare contractors finalize narrow coverage for glioblastoma treatment

    The local coverage determination for Novocure's tumor treatment field therapy will go into effect Sept. 1.

    By Updated July 19, 2019
  • Image attribution tooltip
    Flickr Creative Commons
    Image attribution tooltip

    Sen. Murray renews scrutiny of duodenoscope makers

    The top Democrat on the HELP committee is asking manufacturers Olympus, Fujifilm and Pentax how they plan to respond to FDA data showing what the senator calls "alarmingly high rates of contamination."

    By David Lim • Updated May 13, 2019
  • Image attribution tooltip
    Acelity (courtesy of Maggie Fairchild)
    Image attribution tooltip

    Bound for 3M, KCI gets De Novo for negative pressure device

    The clearance expands use of the negative pressure device for reduction of superficial surgical site infections in high-risk patients. The KCI brand is marketed by Acelity, acquired by 3M last week in a $6.7 billion deal.

    By Maria Rachal • May 10, 2019
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    Eye scan to detect Alzheimer's biomarker gets breakthrough status

    Optina Diagnostics' retinal imaging platform uses artificial intelligence to detect amyloid plaques in the brain and is intended to improve diagnostic accuracy as a non-invasive, low-cost tool.

    By May 10, 2019
  • Medtronic finalizes Titan Spine deal

    The medtech giant will gain a portfolio of titanium interbody implants, bought for an undisclosed amount.

    By Maria Rachal • Updated June 27, 2019
  • Philips, Medtronic team up to create image-guided atrial fibrillation device

    The system will use Philips' dielectric imaging and navigation system to facilitate cryoablation without extensive X-ray imaging.

    By May 10, 2019
  • TransEnterix slumps after selling 1 robotic system in Q1

    TransEnterix expects to sell more systems in the second quarter but investors reacted badly to the results, wiping 29% off the company's stock price.

    By May 10, 2019
  • Takeda sells TachoSil patch to J&J's Ethicon for $400M

    TachoSil, a surgical patch to control bleeding, contributed $155 million in net sales to the Japanese drugmaker's coffers during fiscal year 2018.

    By David Lim • May 9, 2019